Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Merck KGaA. (12/12/17). "Press Release: Allan Gabor Takes Over the Leadership of Merck in China". Darmstadt.

Region Region China
Organisations Organisation Merck (DE) (Group)
  Organisation 2 Pfizer Inc. (NYSE: PFE)
  Group Pfizer (Group)
Products Product CHEMICALS
  Product 2 biopharmaceutical
Persons Person Gabor, E. Allan (Merck (DE) 201801 MAnaging Director + Country Speaker China joined 2013 before Pfizer China)
  Person 2 Jelfs, Alasdair (Merck (DE) 201712 Managin Director China until 201712)
     


Merck, a leading science and technology company, today announced an upcoming leadership change in China. Allan Gabor will succeed Alasdair Jelfs as Managing Director and Country Speaker as of February 1, 2018. He will also take over operational responsibility for the Performance Materials business in China. Additionally, Allan Gabor will become a permanent member of the Performance Materials Leadership Team. In his new position, he will report to Kai Beckmann, CEO Performance Materials and Executive Board member responsible for Asia.

“I am very happy that Allan Gabor, who has extensive management experience, also in China, will be taking on this important task in one of the most important regional markets for Merck. He has known the sector and the country for two decades and has already achieved important advances in our Healthcare business in China,” said Beckmann, who also praised the accomplishments of Alasdair Jelfs: “I thank him for his many years of service in China.” Jelfs will take over other responsibilities at Merck.

The inclusion of the future head of Merck in China in the Performance Materials Leadership Team underscores the strategic importance of the Chinese market to the business sector. The change is part of a realignment of the entire business sector, which under the leadership of Kai Beckmann has developed a strategy to sharpen its focus on markets and customers. The OLED materials business will be combined with the Liquid Crystals business into a single business unit. In addition, all activities pertaining to research, business development and external partnerships will be united in a central research and innovation unit. Production and Supply Chain activities will also be realigned.

Allan Gabor has been working for Merck since 2013 and serves as the Head of the Biopharma business in Asia, including China. He has more than 25 years of management experience in leadership roles in countries such as China, Turkey, Russia, and the United States. Prior to joining Merck, he was head of Pfizer in China, where he has been working since 1999.


For more information, contact Markus Talanow
+49 6151 72-7144
Email


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

   
Record changed: 2018-01-16

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px




» top